International journal of cardiology最新文献

筛选
英文 中文
Letter to the editor: “Performance evaluation of four scoring systems for mortality prediction in a contemporary cardiac intensive care unit” 致编辑的信:“当代心脏重症监护病房四种死亡率预测评分系统的性能评估”
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-17 DOI: 10.1016/j.ijcard.2025.133532
Biao Wang, Yanming Wu
{"title":"Letter to the editor: “Performance evaluation of four scoring systems for mortality prediction in a contemporary cardiac intensive care unit”","authors":"Biao Wang, Yanming Wu","doi":"10.1016/j.ijcard.2025.133532","DOIUrl":"10.1016/j.ijcard.2025.133532","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133532"},"PeriodicalIF":3.2,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144330599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: “Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection” 致编辑的信:“心力衰竭和合并症导致COVID-19感染的负面预后”
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-17 DOI: 10.1016/j.ijcard.2025.133535
Rachana Mehta , Ranjana Sah
{"title":"Letter to the editor: “Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection”","authors":"Rachana Mehta , Ranjana Sah","doi":"10.1016/j.ijcard.2025.133535","DOIUrl":"10.1016/j.ijcard.2025.133535","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133535"},"PeriodicalIF":3.2,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144320874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to “The efficacy and safety of dapagliflozin in pediatric heart failure: Interpreting causality in clinical outcomes” 回复“达格列净治疗儿童心力衰竭的有效性和安全性:临床结果的因果关系解释”
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-17 DOI: 10.1016/j.ijcard.2025.133525
Swasthi S. Kumar, Arun Gopalakrishnan, K.M. Krishnamoorthy, Harikrishnan Sivadasanpillai
{"title":"Reply to “The efficacy and safety of dapagliflozin in pediatric heart failure: Interpreting causality in clinical outcomes”","authors":"Swasthi S. Kumar, Arun Gopalakrishnan, K.M. Krishnamoorthy, Harikrishnan Sivadasanpillai","doi":"10.1016/j.ijcard.2025.133525","DOIUrl":"10.1016/j.ijcard.2025.133525","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133525"},"PeriodicalIF":3.2,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144330597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reframing the CHADS-P2A2RC score in chronic coronary syndrome: From ischemic risk stratification to a signal for caution 重构慢性冠状动脉综合征的CHADS-P2A2RC评分:从缺血性危险分层到预警信号
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-17 DOI: 10.1016/j.ijcard.2025.133536
Ahmed B. Shamsulddin
{"title":"Reframing the CHADS-P2A2RC score in chronic coronary syndrome: From ischemic risk stratification to a signal for caution","authors":"Ahmed B. Shamsulddin","doi":"10.1016/j.ijcard.2025.133536","DOIUrl":"10.1016/j.ijcard.2025.133536","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133536"},"PeriodicalIF":3.2,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144330596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radial access crossover for percutaneous coronary procedures and outcome: The REPEAT study 经皮冠状动脉手术的桡动脉通路交叉和结果:REPEAT研究
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-17 DOI: 10.1016/j.ijcard.2025.133523
Alessandro Sciahbasi , Ernesto Cristiano , Enrico Romagnoli , Mauro Pennacchi , Flavia Belloni , Filippo Zilio , Enrico Occhiuzzi , Massimo Mancone , Giuseppe Talanas , Alberto Marrangoni , Simona Minardi , Carmine Musto , Giulia Mattaroccia , Stefano Rigattieri
{"title":"Radial access crossover for percutaneous coronary procedures and outcome: The REPEAT study","authors":"Alessandro Sciahbasi ,&nbsp;Ernesto Cristiano ,&nbsp;Enrico Romagnoli ,&nbsp;Mauro Pennacchi ,&nbsp;Flavia Belloni ,&nbsp;Filippo Zilio ,&nbsp;Enrico Occhiuzzi ,&nbsp;Massimo Mancone ,&nbsp;Giuseppe Talanas ,&nbsp;Alberto Marrangoni ,&nbsp;Simona Minardi ,&nbsp;Carmine Musto ,&nbsp;Giulia Mattaroccia ,&nbsp;Stefano Rigattieri","doi":"10.1016/j.ijcard.2025.133523","DOIUrl":"10.1016/j.ijcard.2025.133523","url":null,"abstract":"<div><h3>Background</h3><div>Transradial approach (TRA), compared with transfemoral, reduces vascular and bleeding complications during percutaneous coronary procedures (PCP) at the expense of a higher conversion rate to another vascular access. Aim of our study was to evaluate the crossover rate and direction (other arm vs femoral access) after primary TRA failure and to assess the clinical impact of access-site crossover.</div></div><div><h3>Methods</h3><div>From July 2022 to January 2025, at 10 experienced radial Centers, we prospectively enrolled all patients with attempted TRA requiring vascular crossover. A control group of effective TRA procedures (with a rate of 2:1 compared to crossover) was also included. Primary endpoint was the rate of in-hospital vascular complications and major bleeding in crossover versus non-crossover groups. Univariate and multivariate analyses were performed to determine independent predictors of TRA crossover.</div></div><div><h3>Results</h3><div>Among 17,462 undergoing TRA-PCP, vascular crossover was needed in 462 patients (2.6 %) and the second alternative vascular access was femoral in the majority of cases (53 %). Compared to controls (895 patients), the rate of major bleeding and vascular complications was significantly higher in the crossover group (7 % vs 1 %, <em>p</em> &lt; 0.001). Patients undergoing femoral access after TRA failure showed higher bleeding and vascular complications compared to patients with a “full arm” approach (9 % vs 3 %, p &lt; 0.001). Female sex was an independent factor associated with a higher rate of crossover, bleeding and vascular complications in the multivariable analysis.</div></div><div><h3>Conclusions</h3><div>The crossover rate during TRA-PCP is low but associated with increased vascular and bleeding complications in particular when a femoral access is required.</div></div>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133523"},"PeriodicalIF":3.2,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144321163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LV-PA coupling in PAH: Addressing measurement uncertainty and therapeutic diversity in prognostic models. 多环芳烃的LV-PA耦合:解决预后模型的测量不确定性和治疗多样性。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-17 DOI: 10.1016/j.ijcard.2025.133527
Jianpeng Li, Weizhuo Wang, Gang Cheng
{"title":"LV-PA coupling in PAH: Addressing measurement uncertainty and therapeutic diversity in prognostic models.","authors":"Jianpeng Li, Weizhuo Wang, Gang Cheng","doi":"10.1016/j.ijcard.2025.133527","DOIUrl":"https://doi.org/10.1016/j.ijcard.2025.133527","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":" ","pages":"133527"},"PeriodicalIF":3.2,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of beta-blocker therapy in Takotsubo cardiomyopathy: Insights from a systematic review and meta-analysis. -受体阻滞剂治疗Takotsubo心肌病的疗效:来自系统回顾和荟萃分析的见解。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-17 DOI: 10.1016/j.ijcard.2025.133538
Yufei Liu, Xingchen Li
{"title":"Efficacy of beta-blocker therapy in Takotsubo cardiomyopathy: Insights from a systematic review and meta-analysis.","authors":"Yufei Liu, Xingchen Li","doi":"10.1016/j.ijcard.2025.133538","DOIUrl":"https://doi.org/10.1016/j.ijcard.2025.133538","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":" ","pages":"133538"},"PeriodicalIF":3.2,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Beta-2 microglobulin: A new marker in postmenopausal cardiovascular risk? 血清β -2微球蛋白:绝经后心血管风险的新指标?
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-16 DOI: 10.1016/j.ijcard.2025.133512
Ana Teresa Timoteo
{"title":"Serum Beta-2 microglobulin: A new marker in postmenopausal cardiovascular risk?","authors":"Ana Teresa Timoteo","doi":"10.1016/j.ijcard.2025.133512","DOIUrl":"10.1016/j.ijcard.2025.133512","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133512"},"PeriodicalIF":3.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144290865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular comorbidities and risk of in-hospital mortality in acute pancreatitis 急性胰腺炎的心血管合并症和住院死亡风险
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-16 DOI: 10.1016/j.ijcard.2025.133508
Masashi Hasebe , Chen-Yang Su
{"title":"Cardiovascular comorbidities and risk of in-hospital mortality in acute pancreatitis","authors":"Masashi Hasebe ,&nbsp;Chen-Yang Su","doi":"10.1016/j.ijcard.2025.133508","DOIUrl":"10.1016/j.ijcard.2025.133508","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133508"},"PeriodicalIF":3.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144320875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate versus staged complete revascularization in patients presenting with multivessel disease and ST- or non-ST-segment elevation acute coronary syndrome 多血管疾病和ST段或非ST段抬高急性冠状动脉综合征患者的立即与分期完全血运重建术
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-16 DOI: 10.1016/j.ijcard.2025.133496
Jacob J. Elscot , Hala Kakar , Wijnand K. den Dekker , Johan Bennett , Manel Sabaté , Giovanni Esposito , Eric Boersma , Eugene McFadden , Hector M. Garcia-Garcia , Nicolas M. Van Mieghem , Roberto Diletti , on behalf of the BIOVASC investigators
{"title":"Immediate versus staged complete revascularization in patients presenting with multivessel disease and ST- or non-ST-segment elevation acute coronary syndrome","authors":"Jacob J. Elscot ,&nbsp;Hala Kakar ,&nbsp;Wijnand K. den Dekker ,&nbsp;Johan Bennett ,&nbsp;Manel Sabaté ,&nbsp;Giovanni Esposito ,&nbsp;Eric Boersma ,&nbsp;Eugene McFadden ,&nbsp;Hector M. Garcia-Garcia ,&nbsp;Nicolas M. Van Mieghem ,&nbsp;Roberto Diletti ,&nbsp;on behalf of the BIOVASC investigators","doi":"10.1016/j.ijcard.2025.133496","DOIUrl":"10.1016/j.ijcard.2025.133496","url":null,"abstract":"<div><h3>Background</h3><div>Recent randomized trials have suggested that immediate complete revascularization (ICR) is a viable alternative to staged complete revascularization (SCR) in patients with acute coronary syndrome (ACS) and multivessel disease. However, long-term outcomes comparing ICR with SCR in ST-segment elevation (STE) and non-ST-segment elevation (NSTE) ACS remain unclear.</div></div><div><h3>Methods</h3><div>This study analyzes 2-year follow-up data from the BIOVASC trial, randomizing ACS patients to ICR or SCR. The primary composite endpoint includes all-cause mortality, myocardial infarction, unplanned ischemia-driven revascularization, and cerebrovascular events. Secondary endpoints evaluate these outcomes individually. Cox regression assessed if STE/NSTE-ACS diagnosis influences treatment effect.</div></div><div><h3>Results</h3><div>In 608 STE-ACS patients, the 2-year cumulative incidence of the primary composite endpoint was 10.9 % (ICR) and 11.7 % (SCR) (risk difference [RD] 0.8 %, 95 % confidence interval [CI] -4.3 % to 5.9 %; <em>P</em> = 0.71). In NSTE-ACS, cumulative incidence was 13.5 % (ICR) and 12.8 % (SCR) (RD −0.7 %, 95 % CI -5.1 % to 3.7 %; <em>P</em> = 0.90). No differential effect was observed comparing ICR with SCR between STE- and NSTE-ACS.</div></div><div><h3>Conclusions</h3><div>ICR did not sustain a significant benefit in terms of the primary and secondary outcomes at 2 years follow-up. In addition, no differential effect of ICR versus SCR was observed between STE-ACS and NSTE-ACS after 2 years follow-up. However, there seems to be a late catch-up in the cumulative event rate in patients randomized to ICR.</div></div>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133496"},"PeriodicalIF":3.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144293717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信